Understanding the risk of recurrence after resection of intraductal papillary mucinous neoplasm-associated adenocarcinoma: insights from a large multicenter study

Hong T Lin; Somashekar G Krishna

doi:10.21037/hbsn-24-583

Understanding the risk of recurrence after resection of intraductal papillary mucinous neoplasm-associated adenocarcinoma: insights from a large multicenter study

Hepatobiliary Surg Nutr. 2024 Dec 1;13(6):1041-1044. doi: 10.21037/hbsn-24-583. Epub 2024 Nov 8.

Authors

Hong T Lin¹, Somashekar G Krishna²

Affiliations

¹ Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
² Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

No abstract available

Keywords: Pancreatic cancer; adjuvant chemotherapy; intraductal papillary mucinous neoplasm (IPMN); pancreatic ductal adenocarcinoma (PDAC); tumor recurrence.

Publication types

Editorial
Comment